Health in Eritrea 1,395 indicators covering health for Eritrea. IndicatorLatest Year10-yr change Rank Under 5 mortality rate - Current trends maintained 28.12 2030 down 15.2% 54th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 79.5% 1st Under 5 mortality rate - SDG target met 24.19 2030 down 25.1% 41st Mortality rate age 10-19 - Remains constant 9.82 2030 down 3.2% 34th Mortality rate age 10-19 - Current trends maintained 8.88 2030 down 11.0% 35th Mortality rate age 10-19 - High-income country average rate matched 5.66 2030 down 35.4% 2nd Neonatal deaths - Remains constant 1,748 2030 up 8.4% 80th Neonatal deaths - Current trends maintained 1,511 2030 down 3.9% 79th Neonatal deaths - SDG target met 1,343 2030 down 12.9% 80th Under-five deaths - Remains constant 3,766 2030 up 8.9% 75th Under-five deaths - Current trends maintained 3,089 2030 down 7.7% 77th Under-five deaths - SDG target met 2,663 2030 down 18.2% 79th Deaths age 10 to 19 - Remains constant 894 2030 up 0.7% 84th Deaths age 10 to 19 - Current trends maintained 784 2030 down 9.7% 84th Number of deaths attributed to non-communicable diseases, by type of 1,761 2019 up 21.3% 140th Hepatitis B surface antigen (HBsAg) prevalence 0.5% 2024 down 28.6% 59th Mortality caused by road traffic injury 37.9 per 100,000 population 2019 up 11.5% 5th Mortality caused by road traffic injury, female 21 per 100,000 female population 2019 up 22.1% 10th Mortality caused by road traffic injury, male 54.8 per 100,000 male population 2019 up 8.1% 5th Number of new G2D leprosy cases 1 2025 down 80.0% 78th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.277 2025 down 73.1% 67th Share of one-year-olds who received the inactivated polio vaccine 95.0% 2024 up 227.6% 82nd Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2023 — 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2023 — 33rd HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 22.0% 1st Tuberculosis patients living with HIV receiving antiretroviral therapy 41 patients 2021 — 90th Hospital beds 10.22 2023 down 17.9% 124th Treatment success rate for patients treated for MDR-TB 81.0% 2022 down 19.0% 46th Treatment success rate: HIV-positive TB cases 93 2023 up 17.7% 17th Estimated number of children (aged 0-17 years) who have lost one or 110,000 2024 down 15.4% 80th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 93.0% 2025 — 64th International Health Regulations core capacity scores, SPAR version 40 2025 — 112th Estimated number of malaria cases 362,132 2024 up 230.1% 41st Children (0-14) living with HIV 500 2024 down 39.0% 66th Deaths in armed conflicts, annual growth rate -100 % change on previous year 2023 — 46th Number of one-year-olds who have not received the inactivated polio vaccine 4,692 one-year-olds 2023 down 92.6% 107th Children living with HIV 500 0-14 2024 down 39.0% 66th Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Annual number of children newly infected with HIV 100 ages 0-14 2024 unchanged 51st Children newly infected with HIV 22.66 infections 2024 down 24.7% 75th Estimated number of children needing antiretroviral therapy based on 500 2025 down 33.3% 64th Estimated number of malaria deaths 786 2024 up 246.3% 39th National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 157th Number of prevalent tuberculosis cases 6,300 2014 down 31.5% 94th Estimated malaria incidence 102.42 2024 up 189.0% 32nd Estimated malaria mortality rate 22.23 2024 up 203.1% 34th Number of new leprosy cases with G2D among children 0 2025 — 33rd Estimated antiretroviral therapy coverage among children 63 2025 up 6.8% 24th Inflation-adjusted prices for most sold brand of cigarettes: Prices 23.4 2018 up 203.9% 2nd Taxes as a % of price: total tax 55.4% 2018 unchanged 94th Taxes as a % of price: ad valorem excise 44.6% 2018 unchanged 21st Taxes as a % of price: specific excise 0.0% 2018 — 135th Taxes as a % of price: import duties 0.0% 2018 — 38th Taxes as a % of price: other taxes 0.0% 2018 — 57th Taxes as a % of price: value added tax 10.7% 2018 unchanged 122nd Vitamin A supplementation coverage rate 78.0% 2021 up 100.0% 22nd Inflation-adjusted prices for most sold brand of cigarettes: Price in 122.51 2018 up 132.8% 69th Physical activity policies for activie societies -10 2023 down 110.0% 193rd Physical activity policies focused on active systems -10 2023 down 200.0% 190th ← Previous Page 21 of 24 Next →